Blog
RSS FeedPosted by Michael Wonder on 25 Oct 2019
Proposal to award sole supply for apomorphine hydrochloride
25 October 2019 - PHARMAC is proposing to make changes to the funding of apomorphine hydrochloride, a medicine used to ...
Posted by Michael Wonder on 24 Oct 2019
Mother fears daughter's death linked to PHARMAC's epilepsy drug switch
25 October 2019 - A woman who fears her daughter's death is linked to a change in her epilepsy medicine is ...
Posted by Michael Wonder on 23 Oct 2019
'You can't ignore cost': PHARMAC bosses recognise drug-buying constraints, promise transparency
23 October 2019 - PHARMAC's chief executive Sarah Fitt is defending the drug-buying agency in the face of petitioners calling ...
Posted by Michael Wonder on 22 Oct 2019
Proposal to widen access to bortezomib for multiple myeloma and amyloidosis
22 October 2019 - PHARMAC is seeking feedback on the proposal to change the Special Authority criteria for bortezomib. ...
Posted by Michael Wonder on 21 Oct 2019
Proposal to award sole supply for fluticasone and fluticasone with salmeterol metered dose inhalers
21 October 2019 - PHARMAC is seeking feedback on a proposal to make changes to the funded brands of fluticasone ...
Posted by Michael Wonder on 18 Oct 2019
PHARMAC publishes draft agenda for November 2019 PTAC meeting
18 October 2019 - Eight agenda items; not one new medicine/product. ...
Posted by Michael Wonder on 17 Oct 2019
Deputy Prime Minister admits PHARMAC needs more money
16 October 2019 - Patient Voice Aotearoa welcomes the comments made by the Deputy Prime Minister Winston Peters on ‘The Project’ ...
Posted by Michael Wonder on 16 Oct 2019
IUD appointments booked out until 2020 after PHARMAC announces funding
16 October 2019 - Family Planning says demand for the newly funded Mirena and Jaydess contraceptives is so high, the ...
Posted by Michael Wonder on 14 Oct 2019
21,000 to benefit from Mirena and Jaydess
14 October 2019 - PHARMAC is widening funded access to Mirena, as well as listing a new long-acting reversible contraceptive ...
Posted by Michael Wonder on 10 Oct 2019
'I'm not ready to bring her back' - NZ not safe for three-year-old with motor neuron disease, mum says
10 October 2019 - Three-year-old New Zealander Charlotte Bond is showing signs she may walk again on her own with ...
Posted by Michael Wonder on 08 Oct 2019
Cancer patients to benefit from new PHARMAC funded drugs
8 October 2019 - Cancer patient advocates are welcoming PHARMAC's decision to pay for two new drugs but say New Zealand ...
Posted by Michael Wonder on 08 Oct 2019
Proposal to increase the subsidy for hexamine hippurate tablets and for flecainide acetate injection
8 October 2019 - PHARMAC is seeking feedback on a proposal to increase the subsidy payable for two currently funded ...
Posted by Michael Wonder on 07 Oct 2019
New PHARMAC drug funding approved but some New Zealanders still missing out
8 October 2019 - A Motueka woman living with multiple sclerosis is vowing to fight for access to a drug ...
Posted by Michael Wonder on 07 Oct 2019
'Left on the scrapheap': PHARMAC decision bittersweet for MS patients
7 October 2019 - A Motueka grandmother says the national drug-buying agency is abandoning her on the scrapheap with "inhumane" ...
Posted by Michael Wonder on 07 Oct 2019
Jacinda Ardern hails 'exciting phase' of cancer research as PHARMAC funds three new drugs
7 October 2019 - The $40 million boost to PHARMAC's funding has paid for three new medicines to be available ...